SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-002543
Filing Date
2022-01-10
Accepted
2022-01-10 08:56:07
Documents
14
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm222297d1_8k.htm   iXBRL 8-K 27969
2 EXHIBIT 99.1 tm222297d1_ex99-1.htm EX-99.1 30283
6 GRAPHIC tm222297d1_ex99-1img001.jpg GRAPHIC 3953
  Complete submission text file 0001104659-22-002543.txt   245769

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA knsa-20220110.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20220110_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20220110_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT tm222297d1_8k_htm.xml XML 3612
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 22519933
SIC: 2834 Pharmaceutical Preparations